Creates a safe and inclusive space.
Patient, kind, and always approachable.
This comment is not public.
Mohammadreza Mohebbi is an Associate Professor in the Faculty of Health at Deakin University, affiliated with the Office of the Executive Dean Health and the Institute for Mental and Physical Health and Clinical Translation (IMPACT). He joined the Deakin Biostatistics Unit in April 2013 as a senior research fellow, progressing to his current position as Associate Professor. In this role, Mohebbi leads the quantitative aspects of clinical trials and epidemiological studies. His research specializations include biostatistics, epidemiology, and clinical trials, with particular expertise in designing and analysing large-scale clinical trials, longitudinal data analysis, and epidemiological investigations. He serves as principal supervisor for seven Deakin PhD students and as co-supervisor for one additional student. Additionally, Mohebbi is the Theme Leader for Mental Health and Neuroscience within Deakin's research initiatives.
Mohebbi's scholarly output includes over 200 publications, with significant citation impact exceeding 4,000 according to academic profiles. Key publications feature "Psychotropic medication use and bone loss in men: longitudinal study" (2026, co-authored with Weerasinghe, Hodge, Samarasinghe, and Williams), "Depressive Symptoms and Gut Microbiota after Bowel Preparation and Colonoscopy: A Pre-post Intervention Study" (2024, McGuinness et al.), "Modifiable Lifestyle Factors and Cognitive Function: A Population-Based Study Amongst Nondemented Men" (2024, Corney et al.), "The Dietary Inflammatory Index Is Associated with Low Muscle Strength among Men: A Population-Based Study" (2021, Gojanovic et al.), "Physical multimorbidity, depression, and mortality" (2019, International Journal of Geriatric Psychiatry, Mohebbi et al.), and the protocol for "An international, double-blind, randomized, placebo-controlled clinical trial of adjunctive trimetazidine to treat people with bipolar depression: the TIDE trial" (2024). These works address critical intersections of diet, medication, lifestyle factors, and mental health outcomes, particularly in older adults and clinical cohorts, enhancing methodological standards in health research.
